Company Filing History:
21 out of 23 
1 out of 1 Years Active: 2013-2025
Title: Innovations and Inventions of Jens Schouenborg
Introduction: Jens Schouenborg is a notable inventor based in Lund, Sweden, who has made significant contributions in the field of biomedical engineering. With a remarkable portfolio of 21 patents, Schouenborg's work primarily focuses on optimizing methods for stimulating excitable tissues, which has the potential to enhance medical treatments for patients.
Latest Patents: Some of Jens Schouenborg's latest patents include innovative methods that demonstrate his expertise and commitment to advancing medical technology. One such patent is a "Method and system for improving stimulation of excitable tissue." This method involves optimizing the stimulation specificity of implanted electrodes, enhancing the efficacy of treatment by assessing the therapeutic effects through patient feedback. Another significant patent is the "Method of microelectrode identification," which features a unique identification system for microelectrodes used in soft tissue applications. This method ensures precise detection through advanced imaging techniques, thereby improving the reliability of microelectrode applications in clinical settings.
Career Highlights: Jens Schouenborg has worked with notable companies in his career, including Neuronano AB and Nauronano AB. His experience in these organizations has allowed him to develop and test groundbreaking technology in the biomedical field, solidifying his reputation as an innovator and leader in healthcare advancements.
Collaborations: Throughout his career, Jens has collaborated with various esteemed professionals, including Per Petersson and Fredrik Ek. These collaborations have contributed to the development of his patents and have enabled him to push the boundaries of innovation within the biomedical engineering landscape.
Conclusion: Jens Schouenborg's contributions to the field of medical technology through his patents and collaborations highlight his commitment to improving patient care. His innovative methods and systems reflect the potential to advance clinical practices and enhance therapeutic outcomes for patients with excitably stimulated tissues. The impact of his work continues to influence the biomedical sector, paving the way for future advancements.